GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Birzeit Pharmaceutical Co (XPAE:BPC) » Definitions » Stock Based Compensation

Birzeit Pharmaceutical Co (XPAE:BPC) Stock Based Compensation : $0.00 Mil (TTM As of Dec. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Birzeit Pharmaceutical Co Stock Based Compensation?

Birzeit Pharmaceutical Co's Stock Based Compensation for the three months ended in Dec. 2024 was $0.00 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2024 was $0.00 Mil.


Birzeit Pharmaceutical Co Stock Based Compensation Historical Data

The historical data trend for Birzeit Pharmaceutical Co's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Birzeit Pharmaceutical Co Stock Based Compensation Chart

Birzeit Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Birzeit Pharmaceutical Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Birzeit Pharmaceutical Co Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.


Birzeit Pharmaceutical Co Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Birzeit Pharmaceutical Co's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.


Birzeit Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
Industrial Zone, P.O. Box 79, Ramallah, PSE
Birzeit Pharmaceutical Co is engaged in manufacturing pharmaceutical products. It produces Ampoules, Capsules, Tablets and Caplets, Syrups, Suspensions and Granules, Ophthalmic, Semi-solids, Powder vials, Suppositories, and Powders. It serves the Ministry of Health, local healthcare organizations, international healthcare organizations and programs, and end users through pharmacies and physicians. It carries out its activity in Palestine, Algeria, and East Europe.

Birzeit Pharmaceutical Co Headlines

No Headlines